Purchases and Sales Made in Q4 2023 in Bio Line Rx Ltd. (BLRX)
This table provides information about the institutional ownership of Bio Line Rx Ltd. (BLRX) during Q4 2023. The information is specifically focused on institutions that hold shares of BioLineRx Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 16, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
170K+ 248.15% |
$222K - $316K
|
238K
$114K
|
|
|
Feb 13, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
62.5K+ 35.56% |
$81.9K - $116K
|
238K
$114K
|
|
|
Mar 12, 2024
Q4 2023
|
Pvg Asset Management Corp
Golden, CO |
BUY
|
- |
61.8KNew |
$81K - $115K
|
61.8K
$29.7K
|
|
|
Feb 13, 2024
Q4 2023
|
Qube Research & Technologies LTD
London, X0 |
BUY
|
- |
40.4K+ 115428.57% |
$52.9K - $75.1K
|
40.4K
$19.4K
|
|
|
Feb 12, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
23KNew |
$30.1K - $42.7K
|
23K
$11K
|
|
|
Feb 08, 2024
Q4 2023
|
North Rock Partners, LLC
|
BUY
|
- |
17.1KNew |
$22.4K - $31.9K
|
17.1K
$8.22K
|
|
|
Feb 13, 2024
Q4 2023
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
7.97K+ 24.88% |
$10.4K - $14.8K
|
40K
$19.2K
|
|
|
Feb 26, 2024
Q4 2023
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
7.12K+ 30.67% |
$9.33K - $13.2K
|
30.4K
$14.6K
|
|
|
Jan 18, 2024
Q4 2023
|
Values First Advisors, Inc.
|
BUY
|
- |
3.82K+ 7.9% |
$5K - $7.11K
|
52.2K
$25K
|
|
|
Feb 08, 2024
Q4 2023
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
3.46K+ 22.54% |
$4.53K - $6.43K
|
18.8K
$9.02K
|
|
|
Jan 18, 2024
Q4 2023
|
Ronald Blue Trust, Inc.
Brentwood, TN |
BUY
|
- |
117New |
$153 - $218
|
117
$56.2
|
|
|
Feb 07, 2024
Q4 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 14, 2024
Q4 2023
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-1.99K- 96.79% |
$2.6K - $3.7K
|
66
$31.7
|
|
|
Mar 15, 2024
Q4 2023
|
National Asset Management, Inc.
Boca Raton, FL |
SELL
|
- |
-2.01K- 9.44% |
$2.63K - $3.74K
|
19.3K
$9.26K
|
|
|
Feb 13, 2024
Q4 2023
|
Cetera Investment Advisers
Schaumburg, IL |
SELL
|
- |
-3.98K- 26.76% |
$5.21K - $7.4K
|
10.9K
$5.22K
|
|
|
Feb 09, 2024
Q4 2023
|
Ubs Group Ag
|
SELL
|
- |
-8.98K- 96.77% |
$11.8K - $16.7K
|
300
$144
|
|
|
Feb 12, 2024
Q4 2023
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-9.87K- 40.79% |
$12.9K - $18.4K
|
14.3K
$6.88K
|
|
|
Jan 22, 2024
Q4 2023
|
Allen Mooney & Barnes Investment Advisors LLC
Thomasville, GA |
SELL
|
- |
-10K- 40.0% |
$13.1K - $18.6K
|
15K
$7.2K
|
|
|
Feb 13, 2024
Q4 2023
|
Envestnet Asset Management Inc
|
SELL
|
- |
-11.5K- 19.76% |
$15K - $21.4K
|
46.6K
$22.4K
|
|
|
Feb 14, 2024
Q4 2023
|
Lpl Financial LLC
Fort Mill, SC |
SELL
|
- |
-13.4K- 11.77% |
$17.5K - $24.9K
|
100K
$48.2K
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-34.7K- 58.93% |
$45.5K - $64.6K
|
24.2K
$11.6K
|
|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-107K- 45.23% |
$141K - $200K
|
130K
$62.4K
|